Atopic Dermatitis
Latest News
Air pollution may be causing eczema
There are now more than three times as many eczema cases as there were in the 1970s, and it now affects as many as 20% of children and 10% of...
Latest News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
Latest News
Lebrikizumab monotherapy for AD found safe, effective during induction
Latest News
How to help pediatricians apply peanut allergy guidelines
Researchers are testing whether a two-part intervention, which includes training videos and a clinical decision support tool, helps pediatricians...
Latest News
FDA expands oral JAK abrocitinib to adolescents with AD
The indication has been expanded for those aged 12-17 whose disease is not adequately controlled with other systemic drugs, including biologics,...
Latest News
Age-related atopic dermatitis phenotypes evaluated in study
“Improved understanding of the clinical phenotypes of AD may help guide choice of treatment and improve health outcomes,” the researchers wrote....
Latest News
AD outcomes improved with lebrikizumab and topical steroids
The percentage of patients who achieved the combined endpoint was more than double for the lebrikizumab plus TCS group vs. the group on TCS alone...
Latest News
Cochrane Review bolsters case that emollients don’t prevent AD
But that message is being diluted by a stream of contradictory conclusions from poor-quality systematic reviews, authors say.
Latest News
Dupilumab significantly improves markers of AD severity in pediatric patients
Of the 19 severity-associated serum biomarkers measured at baseline, week 4, and week 16, markers related to AD severity and treatment response...
Latest News
Parental atopic dermatitis, asthma linked to risk of AD in offspring
The detailed analysis of AD risk associated with parental atopy in early life “may help to risk stratify infants to optimize early interventions...
Latest News
Brepocitinib improves symptoms of mild to moderate AD in phase 2b trial
In addition to AD, brepocitinib is currently being developed as a treatment for dermatomyositis, systemic lupus erythematosus, hidradenitis...